GlassScriptPhysician profile
Scott Raymond Monnin
NPI 1053462150
$4,656.61
in general payments reported to CMS, 2019-2025
38 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,460 · 2020: $284 · 2021: $432 · 2022: $876 · 2023: $443 · 2024: $701 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $773.47 | 2019-2025 | Bodyguardian, General - Molecular Intervention, Synergy |
| Novartis Pharmaceuticals Corporation | $467.33 | 2019-2025 | |
| Amgen INC. | $419.49 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $413.83 | 2019-2025 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $308.88 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $289.29 | 2019-2024 | |
| Medtronic, INC. | $221.18 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.60 | 2019-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $202.21 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.74 | 2019-2022 | |
| Lundbeck LLC | $129.40 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $124.18 | 2019-2025 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $112.54 | 2019 | |
| Chiesi USA, INC. | $102.42 | 2019-2024 | Kengreal, Cleviprex |
| Pfizer INC. | $101.49 | 2022-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $66.98 | 2024 | Turnpike |
| Amarin Pharma, INC. | $65.94 | 2019-2020 | |
| Abiomed | $57.31 | 2024-2025 | Impella |
| Shockwave Medical, INC | $53.88 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $52.33 | 2021-2025 | Onpattro |
| Arbor Pharmaceuticals, INC. | $39.77 | 2019 | |
| Scpharmaceuticals INC. | $38.45 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $29.48 | 2021-2023 | Arcalyst |
| Esperion Therapeutics, INC. | $27.04 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $24.40 | 2019 | |
| Abbott Laboratories | $21.78 | 2023 | Pressurewire |
| Heartflow, INC. | $17.92 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $17.72 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $16.43 | 2024 | |
| Astellas Pharma US INC | $14.97 | 2019 | |
| Gilead Sciences, INC. | $14.52 | 2019 | |
| Philips North America LLC | $13.76 | 2020 | |
| Novo Nordisk INC | $13.50 | 2019 | |
| Medtronic Vascular, INC. | $13.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.19 | 2021 | |
| Angiodynamics, INC. | $12.79 | 2023 | Alphavac |
| United Therapeutics Corporation | $12.25 | 2019 | |
| Allergan, INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Monnin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.